Skip to contentS
Selectis Health, Inc.
S
GBCSSelectis Health, Inc. Q3 2022 · 10-Q
Revenue$9.58M$9.58M+30.9% vs Q3 2021 Net Income-$990.93K-$990.93KN/M vs Q3 2021 EPS Diluted-$0.33-$0.33N/M vs Q3 2021 Operating Income-$322,281N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Selectis Health, Inc. · CIK 727346 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$991,747N/M Margins · derivedOperating margin-3.4%−13.4 pt vs Q3 2021
Net margin-10.3%−9.6 pt vs Q3 2021
ended Sep 30, 2022 · filed Jan 6, 2023 · 98 d after period end